Severe reduction in lung surfactant in the living organism occurs almost exclusively in newborn humans and animals. The lungs at birth are filled with liquid which is displaced from the airspaces during the first breath into the interstitial tissues, where absorption takes place via lymphatics and directly into the circulation. At the end of the first breath the ability to retain air in the lung during expiration and form a functional residual capacity depends upon the presence of surfactant in the air-liquid interface in the alveoli. If surfactant is deficient (as in human infants or animals delivered well before term) expulsion of air during expiration can be complete. With each successive breath the alveoli have to be reopened from the collapsed state, and the removal of liquid from the lung is impeded.
Gross interference with lung function follows, with the development of hyaline membrane disease (the idiopathic respiratory distress syndrome of the newborn). In this condition deep retractions of the chest wall are present during inspiration, together with cyanosis, a fast respiratory frequency, and expiratory grunting caused by partial closure of the glottis which serves to retard alveolar collapse during expiration. At autopsy total alveolar atelectasis is found, and the dilated terminal airways are lined with eosinophilic hyaline membranes composed largely of condensed plasma proteins and epithelial debris. The presence of plasma proteins in airspaces implies increased permeability of the lung lining (Normandetal. 1970).
Measurements of lung mechanics show that
lung compliance, functional residual capacity and total lung capacity are greatly reduced, while airways resistance is little affected. Pulmonary vascular resistance is raised because of pulmonary vasoconstriction probably caused by the combined effects of atelectasis, hypoxia and acidosis. Right-to-left shunting of blood occurs through the foramen ovale and also, in severely affected infants, the ductus arteriosus; shunts are probably also present through atelectatic lung.
That the severe impairment of gas exchange and reopening of feetal shunts are largely secondary to alveolar collapse can be demonstrated by observing the effects of manoeuvres designed to maintain alveolar inflation. Two main approaches have been tried: (1) Retardation or prevention of alveolar collapse during expiration: continuous positive airway pressure during spontaneous breathing (Gregory et al. 1971) ; positive expiratory pressure in mechanically ventilated infants (Llewellyn & Swyer 1970) . (2) The use of a very long inspiratory phase during mechanical ventilation (Reynolds 1971) . These approaches are effective and synergistic in improving arterial oxygenation and reducing right-to-left shunt (Fig 1) . Both approaches produce comparatively high mean intra-alveolar pressures but they can be employed in the presence of surfactant deficiency with little or no risk of adverse circulatory observations, which were made in a random order consequences such as impairment of venous return to the heart. In very severely affected infants being treated by mechanical ventilation the use of the first approach appears to be less effective than the second, probably because an intra-alveolar pressure during expiration sufficient to maintain totally surfactant-deficient alveoli open (approximately 10-15 cmH20) cannot be applied without severely restricting tidal volume and alveolar ventilation. Today, forty-three years after its existence was first suggested, pulmonary surfactant has achieved respectability and is an object of extensive investigation. Ultrastructural and histochemical evidence is consistent with its postulated presence in the alveolar lining. The granular pneumonocytes are generally agreed to be its source. It is a dynamic component of the lung architecture, demanding continual renewal by cellular synthesis and secretion and requiring adequate metabolic support. Extracted from healthy lungs and purified, pulmonary surfactant has the composition of a structural lipoprotein but is unusual in containing a large amount, about 50%, of anenoic phosphatidylcholine, mainly di-palmitoyl phosphatidylcholine. At the air-water interface it forms a highly stable monomolecular film which, on reduction of surface area, diminishes surface tension to very small values. Its effect on lung compliance and its role in alveolar stability have been clearly demonstrated and are widely accepted. In several diseases characterized by atelectasis it is reduced in quantity or masked, and in such states careful splinting of the lungs with continuous positive pulmonary pressure is proving useful.
Pulmonary surfactant appears in the lungs of foetal mammals about half-way through gestation and increases in amount till term. At about fourfifths of term it is secreted into the alveolar lumina and is carried by extravasated lung fluid into the amniotic cavity, where it is readily detectable.
Current investigations suggest that administration of suitable drugs to the pre-term foetus may accelerate lung development and permit early delivery when there are appropriate obstetrical indications. Clinically applicable procedures are being evaluated which will permit intrauterine assessment of lung maturity to guide such bold management of high-risk pregnancies.
Recent immunological studies show that the protein component of purified surfactant is specific to the lung, tightly bound to the complex, and localized to the alveolar spaces. We can soon expect sensitive and specific assay techniques for experimental studies and diagnostic procedures.
Current work also suggests that surfactant flux is under a significant measure of nervous and humoral control. This concept has far-reaching implications for the role of surfactant in adjustment of the lung to varying physiological and pathological states.
From a historical point of view, it may well turn out that the most important result of the discovery of lung surfactant was to draw the attention of many investigators skilled in biochemistry and cell biology to problems of pulmonary function and disease. It is to be hoped that some of these problems which have proved invincible for decades to the approaches of classical physiology will yield before the onslaught of fresh disciplines.
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